Kathrin Mutze

1.6k total citations · 1 hit paper
27 papers, 1.2k citations indexed

About

Kathrin Mutze is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Kathrin Mutze has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Kathrin Mutze's work include Neonatal Respiratory Health Research (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and CAR-T cell therapy research (5 papers). Kathrin Mutze is often cited by papers focused on Neonatal Respiratory Health Research (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and CAR-T cell therapy research (5 papers). Kathrin Mutze collaborates with scholars based in Germany, United States and Netherlands. Kathrin Mutze's co-authors include Mélanie Königshoff, Darcy E. Wagner, Oliver Eickelberg, Mareike Lehmann, Wioletta Skrońska-Wąsek, Andreas Günther, Hani N. Alsafadi, Chiharu Ota, Michael Lindner and Stephan Klee and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Development.

In The Last Decade

Kathrin Mutze

24 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosisex vivo

2017 299 citations Mareike Lehmann, Kathrin Mutze et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathrin Mutze Germany	17	601	495	157	141	129	27	1.2k
Matthew Ullenbruch United States	18	588 1.0×	392 0.8×	174 1.1×	121 0.9×	75 0.6×	23	1.2k
Saleela M. Ruwanpura Australia	17	413 0.7×	359 0.7×	163 1.0×	77 0.5×	213 1.7×	29	1.2k
Amber L. Degryse United States	12	1.1k 1.9×	388 0.8×	119 0.8×	175 1.2×	140 1.1×	14	1.6k
Chao He United States	18	484 0.8×	350 0.7×	85 0.5×	71 0.5×	56 0.4×	39	1.0k
Sarah Chu United States	11	853 1.4×	454 0.9×	141 0.9×	137 1.0×	95 0.7×	17	1.3k
Annika Andersson‐Sjöland Sweden	17	628 1.0×	219 0.4×	181 1.2×	147 1.0×	70 0.5×	19	994
Iliana Herrera Mexico	11	530 0.9×	278 0.6×	107 0.7×	62 0.4×	103 0.8×	24	904
Riitta Kaarteenaho Finland	25	1.2k 2.0×	287 0.6×	435 2.8×	126 0.9×	172 1.3×	85	1.7k
Shunsuke Minagawa Japan	19	762 1.3×	487 1.0×	386 2.5×	150 1.1×	97 0.8×	48	1.5k
Rochelle L. Argentieri United States	12	638 1.1×	312 0.6×	264 1.7×	118 0.8×	111 0.9×	13	1.2k

Countries citing papers authored by Kathrin Mutze

Since Specialization

Citations

This map shows the geographic impact of Kathrin Mutze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Mutze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Mutze more than expected).

Fields of papers citing papers by Kathrin Mutze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Mutze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Mutze. The network helps show where Kathrin Mutze may publish in the future.

Co-authorship network of co-authors of Kathrin Mutze

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Mutze. A scholar is included among the top collaborators of Kathrin Mutze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Mutze. Kathrin Mutze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bürdek, Maja, Petra U. Prinz, Kathrin Mutze, et al.. (2025). Preclinical Development of Costimulatory Switch Protein (CSP)-Armored NY-ESO-1/LAGE-1a-Specific TCR-T Cells for Therapy of Hard-to-Treat PD-L1-Positive Solid Tumors. SHILAP Revista de lepidopterología. 5(4). 45–45.

Bürdek, Maja, Petra U. Prinz, Kathrin Mutze, et al.. (2025). Characterization of a 3S PRAME VLD-Specific T Cell Receptor and Its Use in Investigational Medicinal Products for TCR-T Therapy of Patients with Myeloid Malignancies. Cancers. 17(2). 242–242. 1 indexed citations

Longinotti, Giulia, Mario Catarinella, Petra U. Prinz, et al.. (2023). 2249P Mitigation of tumor microenvironment-mediated immunosuppression using a PD1-41BB switch protein with optimal affinity tcrs for first-in-class, 3rd generation TCR-T therapies. Annals of Oncology. 34. S1158–S1158.

Coluccio, Andrea, Stefanie Tippmer, Petra U. Prinz, et al.. (2023). Abstract 4057: T cells co-expressing a highly potent NY-ESO-1-specific TCR and a chimeric PD1-41BB co-stimulatory switch receptor show a favorable polyfunctional profile for the treatment of solid tumors. Cancer Research. 83(7_Supplement). 4057–4057.

Salvermoser, Melanie, Monika Braun, Kathrin Mutze, et al.. (2022). T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity. Cancers. 14(8). 1998–1998. 19 indexed citations

Mutze, Kathrin, Mareike Lehmann, Darcy E. Wagner, et al.. (2019). The Oncogene ECT2 Contributes to a Hyperplastic, Proliferative Lung Epithelial Cell Phenotype in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 61(6). 713–726. 16 indexed citations

Lehmann, Mareike, et al.. (2019). Late Breaking Abstract - WNT/ß-catenin signaling induces cellular senescence in lung alveolar epithelial cells. Site cant be reached. PA4122–PA4122. 1 indexed citations

Lehmann, Mareike, Hani N. Alsafadi, Stephan Klee, et al.. (2018). Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis. Respiratory Research. 19(1). 175–175. 90 indexed citations

Skrońska-Wąsek, Wioletta, Kathrin Mutze, Hoeke A. Baarsma, et al.. (2017). Reduced Frizzled Receptor 4 Expression Prevents WNT/β-Catenin–driven Alveolar Lung Repair in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 196(2). 172–185. 85 indexed citations

10.

Burgy, Olivier, et al.. (2017). Cell‐specific expression of runt‐related transcription factor 2 contributes to pulmonary fibrosis. The FASEB Journal. 32(2). 703–716. 30 indexed citations

11.

Baarsma, Hoeke A., Wioletta Skrońska-Wąsek, Kathrin Mutze, et al.. (2016). Noncanonical WNT-5A signaling impairs endogenous lung repair in COPD. The Journal of Experimental Medicine. 214(1). 143–163. 118 indexed citations

12.

Lehmann, Mareike, Kathrin Mutze, Herbert B. Schiller, Darcy E. Wagner, & Mélanie Königshoff. (2016). Increased Alveolar Epithelial Cell Senescence In Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 1 indexed citations

13.

John-Schuster, Gerrit, Alexander Bohla, Kathrin Mutze, et al.. (2015). Coactivator-Associated Arginine Methyltransferase-1 Function in Alveolar Epithelial Senescence and Elastase-Induced Emphysema Susceptibility. American Journal of Respiratory Cell and Molecular Biology. 53(6). 769–781. 15 indexed citations

14.

François, C., JanWillem Duitman, Jan H. von der Thüsen, et al.. (2015). Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis. American Journal of Respiratory and Critical Care Medicine. 193(8). 847–860. 36 indexed citations

15.

Chen, Shanze, Renfu Yin, Kathrin Mutze, et al.. (2015). No involvement of alveolar macrophages in the initiation of carbon nanoparticle induced acute lung inflammation in mice. Particle and Fibre Toxicology. 13(1). 33–33. 29 indexed citations

16.

Skrońska-Wąsek, Wioletta, Kathrin Mutze, & Mélanie Königshoff. (2014). R-spondins induce canonical Wnt signaling in lung epithelial cells. European Respiratory Journal. 44(Suppl 58). P1838–P1838. 1 indexed citations

17.

Keller, Simone, Gisela Keller, Kathrin Mutze, et al.. (2012). Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines. Journal of Cancer Research and Clinical Oncology. 138(5). 843–858. 27 indexed citations

18.

Mutze, Kathrin, Rupert Langer, Felix Schumacher, et al.. (2011). DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer. European Journal of Cancer. 47(12). 1817–1825. 114 indexed citations

19.

Mutze, Kathrin, Rupert Langer, Karen Becker, et al.. (2010). Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer. Annals of Surgical Oncology. 17(12). 3336–3343. 61 indexed citations

20.

Langer, Rupert, Kathrin Mutze, Karen Becker, et al.. (2010). Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study. Journal of Clinical Pathology. 63(11). 994–998. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact